Leeward Investments, LLC - MA 13F: Adds $4.1M to PBH Stake
Key Points
- Leeward Investments raised its holdings in Prestige Consumer Healthcare by 88,693 shares, a 20.3% increase, now totaling 526,609 shares.
- As of October 25, 2026, PBH shares recently traded around $47.80, which is 32.7% below its 52-week high of $71.07.
- Leeward's position represents 2.3% of its overall reported 13F value of about $1.05 billion, ranking it 13th among its 139 total positions.
Get Prestige Consumer Healthcare text alerts
We text you when insiders, Congress, analysts or big funds move on $PBH.
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Prestige Consumer Healthcare Inc. alert may contain errors. Disclosures
On October 23, 2026, Leeward Investments, LLC boosted its position in Prestige Consumer Healthcare Inc. (PBH) by 88,693 shares, increasing its total to 526,609 shares valued at approximately $24.2 million. This information comes from the fund's latest Form 13F filing with the SEC.
PBH
Prestige Consumer Healthcare Inc.
Leeward Investments, LLC - MA vs. the S&P 500
Hypothetical returns from Leeward Investments, LLC - MA's disclosed trades, not real profit or advice. How we model this.
What Changed in Leeward Investments' Prestige Consumer Healthcare Position
Leeward Investments added 88,693 shares to its holdings in Prestige Consumer Healthcare, representing a 20.3% increase. The fund now holds 526,609 shares, worth about $24,155,555.
Where Prestige Consumer Healthcare Fits in Leeward Investments' Portfolio
This position makes up 2.3% of Leeward's total reported 13F value of approximately $1.05 billion. It ranks 13th among the fund's 139 positions.
Other Institutional Activity in Prestige Consumer Healthcare
Ariel Investments, LLC increased its stake by 594,538 shares, now holding 4,868,711 shares valued at about $232.7 million. Fuller & Thaler Asset Management Inc. grew its holdings by 1,165,910 shares, bringing its total to 2,331,821 shares worth approximately $111.5 million. Brandes Investment Partners L.P. also added 1,196,950 shares, now owning 2,051,060 shares valued at about $98 million.
Prestige Consumer Healthcare Inc. Stock Down 3.4%
As of October 25, 2026, PBH shares were trading around $47.80, which is 32.7% below the 52-week high of $71.07. The stock is also currently below its 50-day moving average of $48.79 and its 200-day moving average of $54.50.
Recent Earnings
In its latest fiscal year, Prestige Consumer Healthcare reported revenue of approximately $1.1 billion and an earnings per share (EPS) of $3.57. The next earnings report is scheduled for November 5, 2026.
Insider Buying and Selling at Prestige Consumer Healthcare Inc.
Several insider transactions occurred earlier this year. Jeffrey Zerillo, an officer at the company, sold a total of 2,209 shares at prices ranging from $52.28 to $55.32 on various dates in May 2026.
Analysts Set New Price Targets
The mean price target stands at $67.80, suggesting potential upside from the recent trading price.
About Prestige Consumer Healthcare
Prestige Consumer Healthcare Inc. develops, manufactures, and sells over-the-counter health and personal care products. The company operates in North America and internationally, focusing on providing a range of healthcare solutions. This boost in Leeward's stake indicates confidence in the company as it navigates the competitive healthcare market.
Bottom Line
Leeward Investments' increased stake in Prestige Consumer Healthcare could signal a positive outlook for the company. Investors will be watching closely for the upcoming earnings report on November 5, 2026, to assess the company's ongoing performance.
Related Filing Alerts
Source: Leeward Investments, LLC - MA's 13F filing on $PBH (Oct 23, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Written by software, not financial advice. How we make alerts